Literature DB >> 12598489

Dissociation between skeletal muscle microvascular PO2 and hypoxia-induced microvascular inflammation.

Sidharth Shah1, Julie Allen, John G Wood, Norberto C Gonzalez.   

Abstract

Systemic hypoxia (SHx) produces microvascular inflammation in mesenteric, cremasteric, and pial microcirculations. In anesthetized rats, SHx lowers arterial blood pressure (MABP), which may alter microvascular blood flow and microvascular Po(2) (Pm(O(2))) and influence SHx-induced leukocyte-endothelial adherence (LEA). These experiments attempted to determine the individual contributions of the decreases in Pm(O(2)), venular blood flow and shear rate, and MABP to the hypoxia-induced increase in LEA. Cremaster microcirculation of anesthetized rats was visualized by intravital microscopy. Pm(O(2)) was measured by a phosphorescence-quenching method. SHx [inspired Po(2) of 70 Torr for 10 min, MABP of 65 +/- 3 mmHg, arterial Po(2) (Pa(O(2))) of 33 +/- 1 Torr] and cremaster ischemia (MABP of 111 +/- 7 mmHg, Pa(O(2)) of 86 +/- 3 Torr) produced similar Pm(O(2)): 7 +/- 2 and 6 +/- 2 Torr, respectively. However, LEA increased only in SHx (1.9 +/- 0.9 vs. 11.2 +/- 1.1 leukocytes/100 microm, control vs. SHx, P < 0.05). Phentolamine-induced hypotension (MABP of 55 +/- 4 mmHg) in normoxia lowered Pm(O(2)) to 26 +/- 6 Torr but did not increase LEA. Cremaster equilibration with 95% N(2)-5% CO(2) during air breathing (Pa(O(2)) of 80 +/- 1 Torr) lowered Pm(O(2)) to 6 +/- 1 Torr but did not increase LEA. On the other hand, when cremaster Pm(O(2)) was maintained at 60-70 Torr during SHx (Pa(O(2)) of 35 +/- 1 Torr), LEA increased from 2.1 +/- 1.1 to 11.1 +/- 1.5 leukocytes/100 microm (P < 0.05). The results show a dissociation between Pm(O(2)) and LEA and support the idea that SHx results in the release of a mediator responsible for the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598489     DOI: 10.1152/japplphysiol.01185.2002

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

Review 1.  Arteriolar oxygen reactivity: where is the sensor and what is the mechanism of action?

Authors:  William F Jackson
Journal:  J Physiol       Date:  2016-07-21       Impact factor: 5.182

2.  Monocyte chemoattractant protein-1 released from alveolar macrophages mediates the systemic inflammation of acute alveolar hypoxia.

Authors:  Jie Chao; Paula Donham; Nico van Rooijen; John G Wood; Norberto C Gonzalez
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-02       Impact factor: 6.914

3.  Dexamethasone blocks the systemic inflammation of alveolar hypoxia at several sites in the inflammatory cascade.

Authors:  Jie Chao; Zachary Viets; Paula Donham; John G Wood; Norberto C Gonzalez
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-18       Impact factor: 4.733

4.  Renin released from mast cells activated by circulating MCP-1 initiates the microvascular phase of the systemic inflammation of alveolar hypoxia.

Authors:  Jie Chao; Gustavo Blanco; John G Wood; Norberto C Gonzalez
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-30       Impact factor: 4.733

Review 5.  Alveolar hypoxia-induced systemic inflammation: what low PO(2) does and does not do.

Authors:  Norberto C Gonzalez; John G Wood
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 6.  Alveolar macrophages initiate the systemic microvascular inflammatory response to alveolar hypoxia.

Authors:  Jie Chao; John G Wood; Norberto C Gonzalez
Journal:  Respir Physiol Neurobiol       Date:  2011-03-21       Impact factor: 1.931

7.  The systemic inflammation of alveolar hypoxia is initiated by alveolar macrophage-borne mediator(s).

Authors:  Jie Chao; John G Wood; Victor Gustavo Blanco; Norberto C Gonzalez
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-24       Impact factor: 6.914

Review 8.  Alveolar hypoxia, alveolar macrophages, and systemic inflammation.

Authors:  Jie Chao; John G Wood; Norberto C Gonzalez
Journal:  Respir Res       Date:  2009-06-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.